Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
33.20
Dollar change
+0.57
Percentage change
1.75
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Shs Outstand Perf Week-0.42%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings45 Perf Month0.21%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM81.03M Perf Quarter1.53%
Index- Average Maturity Tagstechnology Return% 10Y NAV% Perf Half Y2.88%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M0.82% 52W Range26.26 - 36.03 Perf YTD8.46%
Dividend TTM- ESG Type Tags- Flows% 3M-2.30% 52W High-7.85% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD326.48% 52W Low26.43% ATR (14)0.42
Expense0.75% Structure Type Region Flows% 1Y RSI (14)44.17 Volatility0.94% 1.01%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.60 Prev Close32.63
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume17.50K Price33.20
SMA20-1.02% SMA50-2.40% SMA200-0.06% Trades Volume10,572 Change1.75%
Apr-22-24 11:10AM
Mar-13-24 12:40PM
Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.